The United States Drug Enforcement Administration has decided to reject a pair of administrative rescheduling petitions challenging the federal classification of cannabis as a Schedule I controlled substance with no accepted medical utility, according to advanced news reports published this evening by NPR, the New York Times, Reuters, and other news outlets.
The DEA announced that they will amend their quotas for 2017 regarding the cultivation of research-grade marijuana and hemp legalization bills in Pennsylvania and Rhode Island have been signed into law! We also have updates from Illinois, Florida, and Ohio. Click here to learn the latest in marijuana law reform news from around the country and to find out how you can #TakeAction!
Federal lawmakers pressured President Obama this week to take executive action to reform marijuana policy. Meanwhile, state legislative reforms are still moving forward throughout the country. Click here to get the latest news and to learn what you can do to take action.
A recent memorandum from the US Drug Enforcement Administration to several United States Senators indicates that the agency is prepared to respond in the coming months to a five-year-old petition seeking to amend the plant’s status as a schedule I prohibited substance. Under the US Controlled Substances Act of 1970, the cannabis plant and its organic cannabinoids are classified as schedule I prohibited substances — the most restrictive category available under the law. As summarized by the DEA, “Schedule I drugs are the most dangerous drugs of all the drug schedules with potentially severe psychological or physical dependence.” Explicitly, substances in this category must meet three specific inclusion criteria: The substance must possess “a high potential for abuse”; it must…
Vermont Senator and Democrat Presidential candidate Bernie Sanders yesterday pledged to get the federal government out of the marijuana enforcement business by removing the substance from the US Controlled Substances Act.
Friday, September 6, 2013 marks the 25-year anniversary of an administrative ruling which determined that cannabis possesses accepted medical utility and ought to be reclassified accordingly under federal law. The ruling, issued in 1988 by US Drug Enforcement Administration (DEA) Chief Administrative Law Judge Francis Young “In the Matter of Marijuana Rescheduling,” determined: “Marijuana, in its natural form, is one of the safest therapeutically active substances known to man. By any measure of rational analysis marijuana can be safely used within a supervised routine of medical care.”
The U.S. Court of Appeals for the D.C. Circuit will hear opening arguments next week in a lawsuit challenging the federal government’s refusal to consider reclassifying cannabis as a schedule I prohibited substance under federal law. At issue in the case is whether the Drug Enforcement Administration (DEA) acted appropriately when the agency last year denied an administrative petition – initially filed by a coalition of public interest organizations, including NORML, in 2002 – that called on the agency to initiate hearings to reassess the present classification of cannabis. Under […]
Earlier today, United States DEA Administrator Michele Leonhart reaffirmed in the Federal Register the administration’s ‘flat Earth’ position regarding the medical properties of cannabis.
Responding to a nine-year-old petition to reclassify marijuana under federal law filed by a coalition of advocacy groups, including NORML and California NORML, Leonhart stated, “[T]here is no substantial evidence that marijuana […]
A coalition of public interest advocacy groups filed suit today in the US Court of Appeals for the District of Columbia to compel the Obama administration to respond to a nine-year-old petition to reclassify marijuana under federal law.
The suit was filed by attorneys Joe Elford of Americans for Safe Access (ASA) and Michael Kennedy of […]
NORML’s youtube channel, NORML TV, recently launched a new video series entitled ‘Ask NORML,’ which features NORML staff answering questions submitted by you — the marijuana law reform activist.
In the debut episode, NORML founder and legal counsel Keith Stroup speaks about NORML’s past and ongoing efforts to reschedule cannabis under federal law.
Subscribe to NORML TV […]